Global Cell Line Development Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Cell Line Development is the process by which the cellular machinery is co-opted to manufacture therapeutic biologics or other proteins of interest. Increasing demand for monoclonal antibodies, increase investment in hospital infrastructure has led to the adoption of Cell Line Development across the forecast period. For Instance: As per the IBEF, The hospital industry in India is forecast to increase to Rs. 8.6 trillion (US$ 132.84 billion) by FY22 from Rs. 4 trillion (US$ 61.79 billion) in FY17 at a CAGR of 16-17%. Also, with the increasing risk of pandemic and communicable diseases, the adoption & demand for Cell Line Development is likely to increase the market growth during the forecast period. However, developing stable and authentic cell lines impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Cell Line Development market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to increased demand for monoclonal antibodies, rising vaccine production, and the use of innovative technologies. Whereas, North-America is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as increasing demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies would create lucrative growth prospects for the Cell Line Development market across North America region.
Major market players included in this report are:
Sartorius AG (Germany)
American Type Culture Collection (ATCC) (U.S.)
Lonza Group AG (Switzerland)
Thermo Fisher Scientific, Inc. (U.S.)
GE Healthcare (U.K.)
Sigma Aldrich Corporation (U.S.)
Selexis SA (Switzerland)
European Collection of Cell Cultures (ECACC) (U.K.)
Corning, Inc. (U.S.)
Wuxi App Tec, Inc. (China)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Primary Cell Lines
Continuous Cell Lines
Hybridomas
Recombinant Cell Lines
By Product:
Equipment
Media and Reagents
By Source:
Mammalians
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Cell Line Development Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Global Cell Line Development Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Global Cell Line Development Market, by Type, 2020-2028 (USD Billion)
- 1.2.3. Global Cell Line Development Market, by Product, 2020-2028 (USD Billion)
- 1.2.4. Global Cell Line Development Market, by Source, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Cell Line Development Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Cell Line Development Market Dynamics
- 3.1. Cell Line Development Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing demand for monoclonal antibodies
- 3.1.1.2. Increasing investment in hospital infrastructure
- 3.1.2. Market Challenges
- 3.1.2.1. Developing Stable and Authentic Cell Lines
- 3.1.3. Market Opportunities
- 3.1.3.1. Increasing risk of pandemic and communicable diseases
Chapter 4. Global Cell Line Development Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Cell Line Development Market, by Type
- 6.1. Market Snapshot
- 6.2. Global Cell Line Development Market by Type, Performance - Potential Analysis
- 6.3. Global Cell Line Development Market Estimates & Forecasts by Type, 2019-2028 (USD Billion)
- 6.4. Cell Line Development Market, Sub Segment Analysis
- 6.4.1. Primary Cell Lines
- 6.4.2. Continuous Cell Lines
- 6.4.3. Hybridomas
- 6.4.4. Recombinant Cell Lines
Chapter 7. Global Cell Line Development Market, by Product
- 7.1. Market Snapshot
- 7.2. Global Cell Line Development Market by Product, Performance - Potential Analysis
- 7.3. Global Cell Line Development Market Estimates & Forecasts by Product, 2019-2028 (USD Billion)
- 7.4. Cell Line Development Market, Sub Segment Analysis
- 7.4.1. Equipment
- 7.4.2. Media and Reagents
Chapter 8. Global Cell Line Development Market, by Source
- 8.1. Market Snapshot
- 8.2. Global Cell Line Development Market by Source, Performance - Potential Analysis
- 8.3. Global Cell Line Development Market Estimates & Forecasts by Source, 2019-2028 (USD Billion)
- 8.4. Cell Line Development Market, Sub Segment Analysis
Chapter 9. Global Cell Line Development Market, Regional Analysis
- 9.1. Cell Line Development Market, Regional Market Snapshot
- 9.2. North America Cell Line Development Market
- 9.2.1. U.S. Cell Line Development Market
- 9.2.1.1. Type breakdown estimates & forecasts, 2019-2028
- 9.2.1.2. Product breakdown estimates & forecasts, 2019-2028
- 9.2.1.3. Source breakdown estimates & forecasts, 2019-2028
- 9.2.2. Canada Cell Line Development Market
- 9.3. Europe Cell Line Development Market Snapshot
- 9.3.1. U.K. Cell Line Development Market
- 9.3.2. Germany Cell Line Development Market
- 9.3.3. France Cell Line Development Market
- 9.3.4. Spain Cell Line Development Market
- 9.3.5. Italy Cell Line Development Market
- 9.3.6. Rest of Europe Cell Line Development Market
- 9.4. Asia-Pacific Cell Line Development Market Snapshot
- 9.4.1. China Cell Line Development Market
- 9.4.2. India Cell Line Development Market
- 9.4.3. Japan Cell Line Development Market
- 9.4.4. Australia Cell Line Development Market
- 9.4.5. South Korea Cell Line Development Market
- 9.4.6. Rest of Asia Pacific Cell Line Development Market
- 9.5. Latin America Cell Line Development Market Snapshot
- 9.5.1. Brazil Cell Line Development Market
- 9.5.2. Mexico Cell Line Development Market
- 9.6. Rest of The World Cell Line Development Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. Sartorius AG (Germany)
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. Product Summary
- 10.2.1.5. Recent Developments
- 10.2.2. American Type Culture Collection (ATCC) (U.S.)
- 10.2.3. Lonza Group AG (Switzerland)
- 10.2.4. Thermo Fisher Scientific, Inc. (U.S.)
- 10.2.5. GE Healthcare (U.K.)
- 10.2.6. Sigma Aldrich Corporation (U.S.)
- 10.2.7. Selexis SA (Switzerland)
- 10.2.8. European Collection of Cell Cultures (ECACC) (U.K.)
- 10.2.9. Corning, Inc. (U.S.)
- 10.2.10. Wuxi App Tec, Inc. (China)
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption